Genetic Test Can Identify Triple Negative Breast Cancer Treatment Responders
A test including 53 genes can predict who will respond and who will not respond to triple negative breast cancer immunotherapy.
CRISPR/Cas9 based genome editing for targeted transcriptional
Courtney Noah, PhD on LinkedIn: #2023sot
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
Federated learning for predicting histological response to
Understanding the 3D Shape of the Genome Reveals Future Cancer
Diane Garvey on LinkedIn: #dassaultsystèmes #3ds #biovia #quality
RNA Biomarkers and Splicing Help Identify and Target Secondary
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Clinical significance and biology of circulating tumor DNA in high